Investment
Features
FeesSafety
Academy
More
Pluang+

Globe Life to report Q3 2026 earnings; Morgan Stanley cuts price target to $197

Company Fundamentals
09 Oct 2026
Stuart Mooney
View Source
Neutral
Globe Life to report Q3 2026 earnings; Morgan Stanley cuts price target to $197

Globe Life will announce its Q3 2026 financial results on October 21, with a conference call on October 22. Morgan Stanley recently lowered its price target for the stock from $208 to $197, reflecting cautious outlooks. The company, which provides life and supplemental health insurance, currently trades at a price-to-earnings ratio of 10.83 and an earnings yield of 9.38%. Investors will watch the earnings report to gauge the insurer's recent performance and outlook.

Globe Life's upcoming Q3 2026 earnings report is awaited following Morgan Stanley's price target cut to $197. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 10, 2026 01:11 WIB: out of 118 priced US Financial stocks, 70 rose and 47 fell. Notable movers include Apollo Global Management at USD 119.66 with a 3.78% gain and Bit Digital Inc at USD 1.31 down 3.31%.

More News

ZenaTech launches AI-powered smart safety glasses Stacklens for field technicians, with pilots in 2027.

ZenaTech launches AI-powered smart safety glasses Stacklens for field technicians, with pilots in 2027.

ZenaTech introduced Stacklens™, AI-powered smart safety glasses designed for field technicians and industrial workers, integrating hands-free AI assistance, real-time video support, and thermal imaging. The glasses aim to improve efficiency by allowi...

Market News
Bullish
42 minutes ago
Class action lawsuit filed over Compass-Anywhere merger alleging regulatory misrepresentation.

Class action lawsuit filed over Compass-Anywhere merger alleging regulatory misrepresentation.

The Rosen Law Firm has filed a class action lawsuit on behalf of former Anywhere Real Estate shareholders who received Compass, Inc. stock in a January 2026 merger. The suit alleges that Compass and its executives misrepresented their efforts to secu...

Market News
Bearish
2 hours ago
New data supports Furoscix ReadyFlow autoinjector for outpatient edema management in heart failure and CKD.

New data supports Furoscix ReadyFlow autoinjector for outpatient edema management in heart failure and CKD.

MannKind presented new clinical data at HFSA 2026 showing that Furoscix ReadyFlow, an autoinjector delivering subcutaneous furosemide, provides diuretic effects comparable to IV administration for treating edema in heart failure and chronic kidney di...

Market News
Bullish
2 hours ago
Class action lawsuit filed against Millrose Properties over undisclosed $200M property leases causing stock drop

Class action lawsuit filed against Millrose Properties over undisclosed $200M property leases causing stock drop

A securities class action lawsuit was filed against Millrose Properties, Inc. for allegedly misleading investors by not disclosing that it would lease $200 million worth of properties purchased from Lennar at a loss. The lawsuit claims Millrose misre...

Market News
Bearish
2 hours ago
Brookfield Infrastructure delays shareholder meeting to Oct 29 for vote on corporate simplification plan

Brookfield Infrastructure delays shareholder meeting to Oct 29 for vote on corporate simplification plan

Brookfield Infrastructure Corporation has postponed its special shareholder meeting to October 29, 2026, to allow more time for votes on its proposed corporate simplification. The plan aims to merge Brookfield Infrastructure Partners LP and Brookfiel...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App